New research indicate that MSCs offer significant hope for addressing a variety of ailments. This groundbreaking therapy utilizes the delivery of these unique cells, derived from fat tissue, to restore injured organs. While still in clinical trials, early results are encouraging, suggesting advantages for patients with several autoimmune conditions